Imunon Overview
See Imunon's analyst price targets ($10) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$1.58
532.9% upside1 analysts in the last 4 months
High: $10 | Low: $10
No recommendations in the last 4 months.
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-17 | Maxim Group | $10 | 532.9% upside |  |
Imunon posts a target price of $10. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
A target price of $10 for IMNN means covering analysts, on average, see the stock 532.9% upside of $1.58 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.
Context for IMNN's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Imunon's other metric pages and overview cover the third.
Judging Imunon against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $10 here, then scan peer and history charts to see if the gap is persistent.
